AssayIndex
Reports by quarter

Reports submitted in 2025-Q2 · page 13

Gravimetric mass-balance reconciliation became mandatory on new records. Median purity for the quarter is 99.05 % area, n=619. Read the 2025-Q2 state-of-the-index report →

619 records16 pagesmedian on this page 99.00 %updated 30 Jul 2026
ReportCompoundSupplierLotLabQuarterPurity %Water %Recovery %ProvenanceFlagsResult
AX-2025-019754TirzepatideHomopeptideHOMO-2502-U4118Nordanalyt2025-Q298.346.1593.3Buyer-sourced0PASS
AX-2025-018812ExenatideFGPFGP-2504-V8032Medutest2025-Q299.103.8988.9Buyer-sourced1MARGINAL
AX-2025-021202TirzepatidePPGPPG-2503-R7317Janoshik2025-Q299.114.51—Buyer-sourced0PASS
AX-2025-020911SurvodutideWXTWXT-2501-X2463Medutest2025-Q298.043.7790.7Buyer-sourced2MARGINAL
AX-2025-020758SemaglutideSGNSGN-2502-J9369Medutest2025-Q297.715.6395.9Buyer-sourced2FAIL
AX-2025-020442SemaxKPKP-2502-H5248Janoshik2025-Q298.646.54—Buyer-sourced0PASS
AX-2025-020246IpamorelinGGPepsGGPE-2411-B1929PeptideMeter2025-Q299.044.23104.6Buyer-sourced0PASS
AX-2025-020056RetatrutideSWBSWB-2503-P7565PeptideMeter2025-Q298.534.94—Buyer-sourced1MARGINAL
AX-2025-019782GHRP-6HomopeptideHOMO-2504-G4514Janoshik2025-Q299.793.8992.3Buyer-sourced0PASS
AX-2025-019498LiraglutideJEEPJEEP-2411-B9021Janoshik2025-Q299.365.3790.2Buyer-sourced0PASS
AX-2025-019231AOD-9604AMBAMB-2411-S5560Kestrel2025-Q299.425.05—Buyer-sourced0PASS
AX-2025-021197RetatrutidePPGPPG-2501-B7212Janoshik2025-Q298.994.19103.3Laboratory-retained0PASS
AX-2025-021115EpitalonSIGSIG-2505-6146Medutest2025-Q298.939.07101.6Buyer-sourced0FAIL
AX-2025-021028PT-141 (Bremelanotide)BCHBCH-2502-H4585Kestrel2025-Q299.935.8093.4Supplier-supplied0PASS
AX-2025-020175Kisspeptin-10ERPERP-2504-G9130Janoshik2025-Q298.615.15101.2Buyer-sourced1MARGINAL
AX-2025-019987TirzepatideHJHJ-2505-H6642Janoshik2025-Q298.914.9689.6Buyer-sourced1MARGINAL
AX-2025-019432L-Glutathione (reduced)HYBHYB-2502-S7614Janoshik2025-Q299.188.18—Buyer-sourced0PASS
AX-2025-019207TirzepatideSinoPepSNP-2502-X4903Janoshik2025-Q298.615.72100.5Buyer-sourced0PASS
AX-2025-019173TB-500SinoPepSNP-2505-V3856Janoshik2025-Q299.475.34101.6Buyer-sourced0PASS
AX-2025-019116RetatrutideGSPGSP-2411-B2857Kestrel2025-Q297.997.19100.2Buyer-sourced0PASS
AX-2025-019109RetatrutideGSPGSP-2411-B2857Kestrel2025-Q297.987.08—Buyer-sourced1FAIL
AX-2025-018878TB-500TFSTFS-{CAT}-8961Janoshik2025-Q299.685.2095.2Buyer-sourced0PASS
AX-2025-018772MK-677 (Ibutamoren mesylate)FGPFGP-2502-F7880Janoshik2025-Q299.234.5495.0Buyer-sourced0FAIL
AX-2025-018694TB-500QSCQSC-2504-T6759Nordanalyt2025-Q299.813.74100.6Laboratory-retained1MARGINAL
AX-2025-021118EpitalonSIGSIG-2505-6146Medutest2025-Q298.858.78106.5Buyer-sourced0FAIL
AX-2025-021079MOTS-cBCHBCH-2505-J4599VendorInvestigate2025-Q298.043.1389.1Buyer-sourced1MARGINAL
AX-2025-020856IpamorelinCPCCPC-2502-D1911Janoshik2025-Q299.304.6196.6Buyer-sourced1MARGINAL
AX-2025-020850IpamorelinCPCCPC-2502-D1911Medutest2025-Q299.144.78—Supplier-supplied1MARGINAL
AX-2025-020763TirzepatideSGNSGN-2503-P9641Janoshik2025-Q297.783.2396.5Buyer-sourced1MARGINAL
AX-2025-018659Enclomiphene citrateQSCQSC-2501-L5841Janoshik2025-Q299.785.88—Buyer-sourced0FAIL
AX-2025-018576N-Acetyl Semax AmideQYBQYB-2411-G5028Janoshik2025-Q299.939.49100.2Laboratory-retained0PASS
AX-2025-020431KPVMKMMKM-2504-N4868PeptideMeter2025-Q299.765.50—Buyer-sourced0FAIL
AX-2025-020094TirzepatideSWBSWB-2505-R8575Janoshik2025-Q299.012.36—Buyer-sourced1MARGINAL
AX-2025-019543CJC-1295 (no DAC)TFCTFC-2411-M9928Janoshik2025-Q298.912.25106.0Buyer-sourced1FAIL
AX-2025-018907CJC-1295 with DACTFSTFS-{CAT}-1220Janoshik2025-Q299.274.97103.6Buyer-sourced1MARGINAL
AX-2025-018770MK-677 (Ibutamoren mesylate)FGPFGP-2502-F7880Medutest2025-Q299.323.90—Buyer-sourced0FAIL
AX-2025-021060TirzepatideBCHBCH-2501-D4197Janoshik2025-Q296.854.3795.3Buyer-sourced0FAIL
AX-2025-020912SurvodutideWXTWXT-2501-X2463Janoshik2025-Q297.894.15—Buyer-sourced2MARGINAL
AX-2025-020778SelankCPCCPC-2504-F9844Janoshik2025-Q298.848.86—Laboratory-retained0FAIL
AX-2025-020738TriptorelinSGNSGN-2504-A9334Janoshik2025-Q298.275.18—Buyer-sourced0FAIL